Document Detail

Antiarrhythmic propafenone: improving patient outcomes.
MedLine Citation:
PMID:  8508716     Owner:  NLM     Status:  MEDLINE    
Propafenone which is distributed as Rythmol by Knoll Pharmaceuticals (Whippany, New Jersey) is a class IC antiarrhythmic agent approved by the Food and Drug Administration (FDA) for the treatment of patients with life-threatening, malignant ventricular arrhythmias. It is still under investigation for use in patients with non-malignant ventricular arrhythmias, supraventricular arrhythmias, and atrial fibrillation or flutter. This author describes the pharmacokinetics and nurse's role for improving outcomes for patients on propafenone.
L A Brzozowski
Related Documents :
534076 - Cardiac arrhythmias associated with subarachnoid hemorrhage: prospective study.
3129456 - Clinical and electrophysiologic effects of flecainide in patients with refractory ventr...
6720516 - Programmed ventricular stimulation in patients without spontaneous ventricular tachycar...
15273456 - Implantable cardioverter defibrillator therapy in patients with ischemic or non-ischemi...
8503386 - Clostridium difficile infection is a treatable cause of diarrhea in patients with advan...
21700606 - Unrecognised ventricular dysfunction in copd.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Dimensions of critical care nursing : DCCN     Volume:  12     ISSN:  0730-4625     ISO Abbreviation:  Dimens Crit Care Nurs     Publication Date:    1993 May-Jun
Date Detail:
Created Date:  1993-07-15     Completed Date:  1993-07-15     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8211489     Medline TA:  Dimens Crit Care Nurs     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  116-22     Citation Subset:  N    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arrhythmias, Cardiac / drug therapy*,  nursing,  physiopathology
Critical Care
Drug Monitoring
Heart Ventricles
Hemodynamics / drug effects
Propafenone / pharmacology,  therapeutic use*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Loperamide. Survey of studies on mechanism of its antidiarrheal activity.
Next Document:  Powerlessness and the pulmonary alveolar edema patient.